To cite this paper use one of the standards below:
Mangiferin (MGF) is a natural polyphenolic compound with notable therapeutic potential, widely recognized for its strong antioxidant properties and diverse pharmacological benefits. Predominantly found in mango leaves (Mangifera indica L.), MGF has gained increasing interest from the pharmaceutical and cosmetic industries due to its broad bioactivity. This study aimed to optimize the hydroalcoholic maceration process for MGF extraction. Initially, a Taguchi experimental design comprising 09 trials was applied as a preliminary screening method to identify the most influential variables. Key factors enhancing MGF recovery were identified and subsequently refined using a Box-Behnken response surface methodology with 15 experimental runs. The optimal extraction conditions were defined as 39.9 °C, 8 h, and 80% (v/v) ethanol, yielding 41.60 mg of MGF per gram of dry weight (d.w.). The resulting extracts were biochemically characterized for soluble protein content, total reducing sugars, and total phenolic content, confirming their enriched composition. Antioxidant activity, measured by the DPPH radical scavenging assay, revealed an inhibition rate of 87.74% at 10.0 mg/g d.w., with an IC50 of 5.45 mg/g, benchmarked against Trolox, highlighting the extract's potent antioxidant capacity. Future directions include the use of polymeric micelle-based aqueous biphasic systems (ABS) for MGF purification, stability studies under diverse physicochemical parameters, and encapsulation into nanostructured micellar systems to improve its bioavailability and formulation potential. Additionally, the antimicrobial activity of MGF will be assessed against both Gram-positive and Gram-negative bacteria, supporting its potential applications in pharmaceutical and cosmetic formulations. Overall, this study provides a comprehensive and sustainable framework for the extraction, characterization, and innovative utilization of mangiferin as a high-value bioactive compound, reinforcing its relevance across various bioindustrial sectors.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper